Mortgage Blog
More executives worry about AI and other tech investments paying off than a recession ahead
“Executives are far more likely to invest in future growth rather than hunker down,” PwC said.
When can I get a Covid booster? Here’s what to know about fall 2023 vaccines
This fall marks the first time that vaccines will be available to fight the triple threat of Covid-19, flu and respiratory syncytial virus, or RSV, which pose an increased risk to young children, elderly adults and immunocompromised people.
Michael Greenberg, medical head of vaccines in North America at Sanofi ADR (Nasdaq: SNY), says last fall's “tripledemic” — when kids with RSV filled pediatric hospital units as the flu and coronavirus circulated in lockstep — is still fresh on people's minds.
“What…
Report: Waystar preps to to go public with $8 billion IPO
If Waystar does become publicly traded, it could be a boon for Louisville’s health care industry.
South San Francisco cell therapy startup raises $255 million
The company has three factories in the works.
Wesley Medical Center certified as a comprehensive stroke center
Wesley is the only hospital in Kansas to hold the designation from DNV Healthcare.
Drug maker Mallinckrodt to again file for bankruptcy protection
Drug maker Mallinckrodt plc said it has reached a debt restructuring deal with a majority of its lenders and plans to file for Chapter 11 bankruptcy as it faces a large opiod-settlement debt.
St. David’s lines up location for Kyle hospital
The hospital will rise next to an H-E-B in this fast-growing suburb. Click through for more details on the project, including its much higher cost estimate.
Arlington’s Sands Capital co-leads $300M fundraising round in New York fintech
It was the firm's first investment in the fast-growing company.
‘Bullishness is on an upswing’: Charles Schwab trader survey finds recession fears beginning to recede
The latest Charles Schwab Trader Sentiment Survey found that 69% of traders still believe the U.S. economy will enter recession, but that figure is down from 86% in the second quarter and 87% in the first quarter.
Raleigh startup raises $3.5M to advance its lab-grown collagen
The company wants to sustainably commercialize animal-free proteins for applications in a variety of sectors, from health care to food and beverage.